{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:40:11Z","timestamp":1789094411882,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K08480"],"award-info":[{"award-number":["18K08480"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17285"],"award-info":[{"award-number":["20K17285"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.kint.2020.10.041","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T03:26:39Z","timestamp":1607484399000},"page":"885-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity"],"prefix":"10.1016","volume":"99","author":[{"given":"Hirofumi","family":"Hamano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7349","authenticated-orcid":false,"given":"Yasumasa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijo","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Chuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Niimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshi","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Zamami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Izawa-Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licht","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.10.041_bib1","first-page":"169","article-title":"Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity","volume":"67","author":"Campbell","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.kint.2020.10.041_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.10.041_bib3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.kint.2020.10.041_bib4","doi-asserted-by":"crossref","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.kint.2020.10.041_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","article-title":"Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial","volume":"52","author":"Santoso","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1248\/bpb.35.967","article-title":"Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system","volume":"35","author":"Kadoyama","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.kint.2020.10.041_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7150\/ijms.4549","article-title":"Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system","volume":"9","author":"Tamura","year":"2012","journal-title":"AERS. Int J Med Sci"},{"key":"10.1016\/j.kint.2020.10.041_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042866","article-title":"A\u00a0survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class","volume":"7","author":"Hoffman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2020.10.041_bib9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA Adverse Event Reporting System","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.kint.2020.10.041_bib10","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.2196\/jmir.4541","article-title":"Opportunities for web-based drug repositioning: searching for potential antihypertensive agents with hypotension adverse events","volume":"18","author":"Wang","year":"2016","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.kint.2020.10.041_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1603014","article-title":"HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in mice","volume":"3","author":"Hashikawa","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.kint.2020.10.041_bib12","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1038\/s41598-018-29008-2","article-title":"Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis","volume":"8","author":"Horinouchi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2020.10.041_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/HJH.0000000000001898","article-title":"Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses","volume":"37","author":"Izawa-Ishizawa","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2020.10.041_bib14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","article-title":"Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q\/11)-subunits in constitutive and agonist-mediated signaling","volume":"60","author":"Bakker","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12974-016-0600-0","article-title":"Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation","volume":"13","author":"Rocha","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.kint.2020.10.041_bib16","article-title":"Diphenhydramine protects against cisplatin-induced nephrotoxicity","volume":"47","author":"Hanigan","year":"2006","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"10.1016\/j.kint.2020.10.041_bib17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bcp.2005.09.020","article-title":"Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat","volume":"70","author":"Yonezawa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2020.10.041_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"Muller","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-008-0369-5","article-title":"Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)","volume":"379","author":"Zolk","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1523-1755.2005.67102.x","article-title":"MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis","volume":"67","author":"Jo","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.10.041_bib22","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1093\/ndt\/gfm144","article-title":"Effect of JNK inhibition on cisplatin-induced renal damage","volume":"22","author":"Francescato","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2020.10.041_bib23","doi-asserted-by":"crossref","first-page":"F166","DOI":"10.1152\/ajprenal.00401.2004","article-title":"p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice","volume":"289","author":"Ramesh","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2020.10.041_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2005.12.044","article-title":"Histamine receptors are hot in immunopharmacology","volume":"533","author":"Akdis","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40635-016-0109-y","article-title":"Critical role of endogenous histamine in promoting end-organ tissue injury in sepsis","volume":"4","author":"Hattori","year":"2016","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.kint.2020.10.041_bib26","doi-asserted-by":"crossref","first-page":"207084","DOI":"10.1155\/2010\/207084","article-title":"Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review","volume":"2010","author":"Makrilia","year":"2010","journal-title":"Met Based Drugs"},{"key":"10.1016\/j.kint.2020.10.041_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1984.86","article-title":"Uptake and metabolism of cisplatin by rat kidney","volume":"25","author":"Safirstein","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.10.041_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0272-6386(86)80111-1","article-title":"Cisplatin nephrotoxicity","volume":"8","author":"Safirstein","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2020.10.041_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.10.041_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Ciarimboli","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2020.10.041_bib31","first-page":"632","article-title":"Pharmacokinetics of cis-dichlorodiammineplatinum (II) [in Japanese]","volume":"9","author":"Horiuchi","year":"1982","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.kint.2020.10.041_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1987.5.2.304","article-title":"Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity","volume":"5","author":"Reece","year":"1987","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2020.10.041_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002800050548","article-title":"Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients","volume":"39","author":"Nagai","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002800050618","article-title":"Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in\u00a0vivo","volume":"40","author":"Nagai","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.kint.2020.10.041_bib35","first-page":"329","article-title":"Determination of cisplatin in blood compartments of cancer patients","volume":"89","author":"Mustonen","year":"1988","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.kint.2020.10.041_bib36","first-page":"68","article-title":"Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin","volume":"76","author":"Takahashi","year":"1985","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.kint.2020.10.041_bib37","doi-asserted-by":"crossref","first-page":"45597","DOI":"10.18632\/oncotarget.17316","article-title":"Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in\u00a0vitro and in\u00a0vivo via transferrin binding","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2020.10.041_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.12-5-601","article-title":"Management and preparedness for infusion and hypersensitivity reactions","volume":"12","author":"Lenz","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.kint.2020.10.041_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2020.10.041_bib40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1200\/JCO.1998.16.4.1325","article-title":"Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma","volume":"16","author":"Shin","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2020.10.041_bib41","doi-asserted-by":"crossref","first-page":"26375","DOI":"10.1038\/srep26375","article-title":"Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism","volume":"6","author":"Nagashima","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2020.10.041_bib42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1248\/bpb.b14-00191","article-title":"Analysis of the interaction between clopidogrel, aspirin, and proton pump inhibitors using the FDA Adverse Event Reporting System Database","volume":"38","author":"Suzuki","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.kint.2020.10.041_bib43","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1248\/bpb.b15-00253","article-title":"Analysis of neuropsychiatric adverse events in patients treated with oseltamivir in spontaneous adverse event reports","volume":"38","author":"Ueda","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.kint.2020.10.041_bib44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jamaoncol.2017.4526","article-title":"EGFR-TKI-associated interstitial pneumonitis in nivolumab-treated patients with non-small cell lung cancer","volume":"4","author":"Oshima","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.kint.2020.10.041_bib45","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1096\/fj.201802724RR","article-title":"Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress","volume":"33","author":"Ikeda","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2020.10.041_bib46","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1073\/pnas.93.23.13316","article-title":"Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors","volume":"93","author":"Inoue","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.10.041_bib47","doi-asserted-by":"crossref","first-page":"23975","DOI":"10.1038\/srep23975","article-title":"Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPKalpha-regulated autophagy induction","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2020.10.041_bib48","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1038\/s41598-017-11089-0","article-title":"Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice","volume":"7","author":"Ikeda","year":"2017","journal-title":"Sci Rep"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820314113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820314113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:58:27Z","timestamp":1758761907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820314113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0085253820314113"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.10.041","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}